RIMACTAN IV 300 mg, poudre et solvant pour solution pour perfusion France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

rimactan iv 300 mg, poudre et solvant pour solution pour perfusion

sandoz - rifampicine sodique - poudre - 300 mg - composition pour un flacon > rifampicine sodique : 300 mg solvant composition > pas de substance active. :

Tivicay Union européenne - français - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutégravir - infections au vih - antiviraux à usage systémique - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Triumeq Union européenne - français - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infections au vih - antiviraux à usage systémique - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.